Chemoradiotherapy Followed by Surgery for Advanced Paranasal Sinus Cancer

Paranasal Sinus Neoplasms Clinical Trial

Official title:
Preoperative Radiotherapy and Concomitant Chemotherapy Followed by Surgery for Advanced Paranasal Sinus Carcinoma

Status Withdrawn

Clinical Trial Summary

The purpose of this study is to determine the efficacy of concurrent chemotherapy and radiotherapy pre-operatively in patients with advanced paranasal sinus cancer. The main objectives of this study are: 1) to measure the rate of complete response to preoperative chemoradiation and 2) to study the efficacy of combining preoperative chemoradiation and surgery in terms of local control of the cancer two years post treatment.

Clinical Trial Description

n/a

Study Design

Allocation: Non-Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment

Related Conditions & MeSH terms

Paranasal Sinus Neoplasms

Clinical Trial Details

NCT number	NCT00347256
Study type	Interventional
Source	University of Tennessee
Contact
Status	Withdrawn
Phase	N/A

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT00117572` - Docetaxel Based Chemotherapy Plus or Minus Induction Chemotherapy to Decrease Events in Head and Neck Cancer (DeCIDE)	Phase 3
Recruiting	`NCT00970502` - Erlotinib, Celecoxib and Reirradiation for Recurrent Head and Neck Cancer	Phase 1/Phase 2
Completed	`NCT00462735` - Fluorouracil, Hydroxyurea, Cetuximab and Twice-daily Intensity Radiation Therapy for Advanced Head and Neck Cancer	Phase 2